Arthur T. Sands
2019 - Nurix Therapeutics
In 2019, Arthur T. Sands earned a total compensation of $1.5M as President, Chief Executive Officer and Director at Nurix Therapeutics.
Compensation breakdown
| Bonus | $400,000 |
|---|---|
| Option Awards | $352,265 |
| Salary | $474,257 |
| Other | $251,512 |
| Total | $1,478,034 |
Sands received $474.3K in salary, accounting for 32% of the total pay in 2019.
Sands also received $400K in bonus, $352.3K in option awards and $251.5K in other compensation.
Rankings
In 2019, Arthur T. Sands' compensation ranked 7,376th out of 13,971 executives tracked by ExecPay. In other words, Sands earned more than 47.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,376 out of 13,971 | 47th |
Division Manufacturing | 2,850 out of 5,695 | 50th |
Major group Chemicals And Allied Products | 1,067 out of 2,194 | 51st |
Industry group Drugs | 909 out of 1,880 | 52nd |
Industry Pharmaceutical Preparations | 673 out of 1,392 | 52nd |
Source: SEC filing on March 25, 2021.
Sands' colleagues
We found one more compensation record of an executive who worked with Arthur T. Sands at Nurix Therapeutics in 2019.
2019
Gwenn Hansen
Nurix Therapeutics
Chief Scientific Officer
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021